Background: Bacterial artificial chromosomes (BACs) are among the most widely used tools for studies of gene regulation and function in model vertebrates, yet methods for predictable delivery of BAC transgenes to the genome are currently limited. This is because BAC transgenes are usually microinjected as naked DNA into fertilized eggs and are known to integrate as multi-copy concatamers in the genome. Although conventional methods for BAC transgenesis have been very fruitful, complementary methods for generating single copy BAC integrations would be desirable for many applications.
Background
BAC transgenesis has many important applications in basic and applied biomedical research, from the analysis of regulatory elements controlling gene expression to creating animal models of human diseases [1] [2] [3] . Because BACs can hold genomic segments as large as 300 kb, they are invaluable for the analysis of distant cis-regulatory elements [4] , rescue of mutant phenotypes and regulated expression of human disease-related genes in mice [2, 3] . A number of BACs encoding fluorescent reporters have been created by 'recombineering' in bacteria to visualize specific tissues or cell types in vivo [4] [5] [6] .
BAC transgenesis has been carried out by microinjection of naked DNA into the cytoplasm of fertilized eggs in zebrafish [4, 5] or oocyte pronucleus in mice [2, 3] . With these methods, integration of the BAC in the genome occurs at best in ~5-20% of the injected survivors in mice [3] and ~1-3% in zebrafish [5] . A recent extensive study showed that about half of BAC transgenic mice carried 1 to 5 copies of the injected BAC as concatamers at one genomic locus, and the rest carried more than 5 copies, and up to 48 copies, arranged in various orientations [7] . Concatameric transgenes may be associated with silencing, instability, and genetic lesions both inside and around the transgenes [8, 9] that seriously limit important experimental applications [10] . For example, Cre-mediated recombination between two loxP sites [2] placed at defined positions within a BAC can be used to delete precisely a candidate regulatory element, or to remove a cassette for conditional expression, and such applications may be facilitated by single copy integrations.
To deliver single-copy BAC transgenes to the genome, several methods including retroviral transfection into embryonic stem (ES) cells [11] , site-specific homologous recombination in ES cells [5, 12] and intracytoplasmic sperm injection [13] have been developed. While these methods are useful, they involve laborious handling of ES cells or freeze-thawing of sperm, and are not suitable to model organisms without established ES cell lines. Thus, simpler and more versatile methods for BAC transgenesis are still desired.
One potentially versatile approach for single-copy BAC transgenesis is to introduce BACs into the genome via DNA-type transposons. However, to date, no transposon has been reported to have the cargo capacity to carry such large DNA inserts as a BAC clone. The medaka fish Tol2 element is a DNA-type transposon that is active in a wide variety of vertebrate animals [14] . It has been shown that 200 bp and 150 bp from the left and right ends of Tol2, respectively, are cis-sequences essential for transposition, and Tol2 constructs that carried ~10 kb DNA inserts between them can transpose efficiently via a reliable cutand-paste mechanism [15] . Here we demonstrate that Tol2 can carry a BAC clone and describe the first application of any transposon to BAC transgenesis in two major model organisms, zebrafish (Danio rerio) and mice (Mus musculus).
Results and discussion
To test whether Tol2 can carry a BAC, we used a BAC clone isolated from pufferfish (Fugu rubripes) that harbored ~59 kb genomic DNA containing the hoxAa cluster (hoxa5 through hoxa13) and the evx1 gene [16] . We inserted Gal4FF (a modified version of the yeast transcriptional activator Gal4) in frame with the second exon of evx1 by galK-mediated homologous recombination in E. coli [17] . It is expected that Gal4 directs GFP expression in the spinal neurons when the transgenic line is crossed with the UAS:GFP reporter fish [18] . To introduce the Tol2 sequence into the BAC plasmid, we designed a cassette containing the minimal cis-sequences of Tol2 in an inverted orientation separated by a ~1 kb spacer, which we termed iTol2 (Figure 1a and Methods). The iTol2 cassette enables incorporation of the Tol2 cis-sequences essential for transposition into a BAC clone through a single step of homologous recombination. The Tol2-Frevx1:Gal4-BAC plasmid (hereafter referred to as Tol2-BAC) contained 66 kb DNA, including the pufferfish genomic DNA and the backbone vector sequence, between the 200 bp and 150 bp end sequences of Tol2 (Figure 1b) .
We injected the Tol2-BAC plasmid and the transposase mRNA into the cytoplasm of zebrafish fertilized eggs. In 20 of 22 injected embryos, the ~66 kb DNA flanked by the Tol2 cis-sequences was excised from the donor plasmid, indicating that the transposase worked on the iTol2 cassette properly (Figure 1b , c; see additional file 1). Injected embryos were raised to sexual maturity and mated to homozygous UAS:GFP transgenic fish ( Figure 2 ). We found that progeny from 2 of 50 injected fish showed GFP expression in the nervous system, including a medial population of spinal neurons, which is consistent with Evx1 expression in chicks and mice [16] (Figure 2a Next, we tested whether Tol2 can carry a BAC in mice as well. We injected the Tol2-BAC plasmid into the pronucleus and cytoplasm or cytoplasm only of oocytes with the transposase mRNA (Figure 1c and see Additional file 2 - Table S1 ). As a control we injected the same DNA without transposase mRNA. 2 of 7 mice derived from pronuclear and cytoplasmic co-injection showed the presence of the Tol2-BAC DNA in the tail DNA as detected by PCR. In contrast, none of the mice derived from cytoplasmic injections (0 of 4) or control injections (0 of 7) had integrated the Tol2-BAC DNA (see additional file 3). The two PCR positive Tol2-BAC founder mice were raised to sexual maturity and crossed to wild type mice. We analyzed F1 offspring by PCR and found that 3 of 12 F1 from founder No.1 and 9 of 16 F1 from founder No.3 carried the Tol2-BAC transgene (Figure 2h ). Southern blot analysis revealed that the progeny from founder No.1 and No.3 harbored single insertions at two different loci (1A and 3A, Figure 2i ). We performed inverse PCR and cloned the Tol2-BAC genomic junction fragments (GenBank accession AB500928-AB500932). The 3A insertion from founder No.3 was located ~4.6 kb upstream of the Pomc gene on chromosome 12 (Figure 2k ). In addition, another insertion (3B) was detected in the progeny of founder No.3 and mapped to contig AAHY01196472.1 ( Figure  2k ). 8 bp duplications were created at the integration sites, indicating that the integrations were mediated by transposition (Figure 2k, l) . We did not examine founder No.1 further since the BAC integration site could not be mapped (data not shown). Further, we performed PCR analysis using several sets of primers within the Tol2-BAC and confirmed that no gross structural alterations of the Tol2-BAC occurred upon integration in 3A and 3B ( Figure  2j ). In addition, we used semi-quantitative PCR with BACspecific primers to obtain an alternative estimate of BAC copy number. Consistent with our Southern blot and inverse PCR results, we estimated ~1-5 BAC copies in both zebrafish and mouse transgenics (additional file 4).
Our results demonstrate for the first time that a DNA transposable element has an extremely large cargo capacity sufficient for BAC transgenesis in two model vertebrates. Tol2-mediated BAC transgenesis should provide advantages over conventional DNA microinjection. First, it can generate single copy integrations that may be analyzed and mapped on the genome relatively easily. Second, such integrations may not suffer from problems that have been observed in concatemeric integrations of small linear DNA transgenes; i.e., gene silencing, gross rearrangements at the target loci, unwanted mutant phenotypes, etc. Third, it ensures integration of DNA from end to end without obvious rearrangements inside. All of these features have been observed in transgenesis using transposons with smaller inserts in mice and zebrafish [19, 20] . The numbers of transposon insertions transmitted to F1 offspring were even lower in our BAC transgenic experiments probably because much fewer donor molecules were introduced in the nucleus during injection compared to small transposon constructs. While, to our knowledge, the 66 kb DNA is the largest insert for any transposon vector, we have also found that the transposase can catalyze transposition of Tol2 with a 120 kb BAC (additional file 5 and 6). Because iTol2 can be easily introduced into any existing BAC clone or BAC vector to create new BAC libraries, we are continuing further work to extend this method to constructs of larger sizes. While ongoing efforts are aimed at defining the optimal conditions and rate of Tol2-mediated BAC transgenesis, our current methodology should have immediate applications in comparative genomic analysis of cis-regulatory elements and gene functions in mice and zebrafish. Furthermore, it could contribute to development of transposon-based vectors for gene therapy, allowing precise delivery of a number of genes in the same context or of complete chromosomal loci in humans [1, 10] .
Conclusion
Transposon-mediated BAC transgenesis is a new tool for precise delivery of BACs in both zebrafish and mice. It avoids potential multicopy concatameric integrations, allowing confirmation of the completeness of the BAC A scheme for Tol2-mediated BAC transgenesis 
Methods
Construction of iTol2 cassette PCR primers were designed to amplify the minimal ends of Tol2 [15] and connected in an inverted orientation with a ~1 kb DNA spacer.
BAC recombineering
Fugu BAC 240G7 was obtained from Geneservice Ltd, UK and modified by galK-mediated recombination in bacteria [17] . Gal4FF was introduced in frame with exon 2 of evx1 [16] . The iTol2 cassette was introduced ~10 kb downstream of evx1 using primers:
Zebrafish transgenesis 50 ng/μl Tol2-BAC plasmid DNA and 25 ng/μl transposase mRNA were co-injected into one-cell stage zebrafish embryos (TL strain) according to established procedures [18] . Injected fish were raised to sexual maturity and outcrossed to identify transgenic carriers.
Mouse transgenesis
Tol2-BAC plasmid DNA construct was dialyzed against buffer (5 mM Tris, 0.1 mM EDTA) and injected at 14.5 ng/ μl with 10 ng/μl transposase mRNA into the pronucleus, cytoplasm or both of mouse oocytes (B6C3F1) according to standard procedures with minor modifications [2] . We carried out injection into pronucleus and cytoplasm by holding the injection needle for a second in cytoplasm after injecting into pronuclei; this way we deliberately permitted a certain amount of DNA solution to flow into the cytoplasm. We did not notice significant toxicity/death despite the relatively high concentration of the BAC DNA. We did not try lower concentrations of DNA because it was difficult to define a priori the 'most suitable' concentration of 'circular' BAC DNA. However, it has been reported that higher DNA concentrations enhance the overall integration rate for small plasmid constructs [21] and large BAC constructs [22] despite a lower survival rate. Injected embryos were transferred into the oviduct of the pseudopregnant female MCH mice. Newborn mice were genotyped by PCR using DNA extracted from the tails. The animal experiments were approved by the Animal Care and Use Committee of National Institute of Genetics.
Inverse PCR
Zebrafish tail fin or newborn mouse limb genomic DNA was digested with AluI or HaeIII, followed by ligation and PCR according to published procedures with Tol2L-out: 5' ccctgctcgagccgggcccaagtg 3' and Tol2R-out: 5' attatgatcctctagatcagatct 3' and BAC-specific primers. Detailed protocols are available upon request.
Genomic PCR
Internal fragments within Tol2-BAC in transgenic zebrafish or mice were amplified by PCR using the primers listed below. Lane No. refers to the numbers in Figure  2e 
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